Detection Technology: EBIT softer than expected - Evli

DT posted Q2 net sales in line with our expectations, while adj. EBIT fell short of our estimates. Medical market is showing increased uncertainty while security markets are expected to improve. Group sales anticipated to decline in Q3 and grow in H2’23.

Länk till analysen i sin helhet: https://www.evli.com/hubfs/ERP/Raportit/Detection%20Technology/Detection%20Technology%20230803%20Q2%20Earnings%20flash.pdf